Source: Jetacom Autofocus / Shutterstock.com
One of the reasons why cannabis stocks are difficult to trust is their volatility. You just never know where some of these names will end up typically in the weeds if it’s speculative. With Curaleaf, though, you’re at least exposing yourself to an established organization. In this case, CURLF stock ties you into marijuana’s biggest U.S. multi-state operator (MSO).
So far, the results have panned out fairly well. On a year-to-date (YTD) basis, CURLF stock is up over 25%. At the time of writing, shares trade hands at $15, giving the underlying company a market capitalization of $10.45 billion.
2 Marijuana Stocks To Add To Your June 2021 Watchlist dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.
Biggest past-year deals:
Subversive Capital s acquisition of Caliva and Left Coast Ventures ($425 million)
Curaleaf s acquisition of Emmac Life Sciences ($290 million)
Ayr Wellness acquisition of Liberty Health Sciences ($290 million)
Key individuals:
The firm declined to specify the lawyers who led its engagements for Curaleaf, Subversive, and Ayr Wellness.
About:
Stikeman Elliott is one of Canada s largest business law firms. The firm s lawyers worked with Curaleaf on two acquisitions, walked Ayr Wellness through its purchase of Liberty, and represented Canaccord Genuity, the financial advisor to the cannabis SPAC Subversive Capital Acquisition Corp., in its complex merger
From 2015 to 2018, Stikeman regularly worked with Aphria, with The Globe and Mail reporting that the two parted ways after a transaction that drew short-seller scrutiny. The firm declined to comment.
Vertically integrated cannabis company
Ayr Wellness Inc. (CSE:AYR) (OTCQX:AYRWF) reported Wednesday that its revenue spiked 74% year-over-year, reaching $58.4 million in the first quarter of 2021, beating the consensus sales estimates.
The Analyst
Cantor Fitzgerald s analyst Pablo Zuanic reaffirmed their Neutral rating on Ayr s stock, trimming their 12-month price target to $33.5 from $36.
Over the quarter, the Toronto-based company wrapped up the acquisition of Liberty Health Sciences, adding 42 Florida-based stores to its portfolio.
In addition, it purchased Arizona-based Blue Camo LLC, which operates as Oasis, and its three medical and adult-use dispensaries in the greater Phoenix area. Ayr also bought a triple-stacked cultivation and processing facility in Chandler, which spans 10,000 square feet, as well as 86,000 square feet of cultivation property in Phoenix, which is still under development.
Ayr Wellness Announces Launch of Origyn Concentrate Line in Florida streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.